SanBio

SanBio

SanBio

SanBio is focused on regenerative cell medicines for neurological disorders such as stroke, traumatic brain injury, diseases of the eye, and Parkinson's disease.
Raised
$20M
Follow us
Alexa global traffic share
Latest funding
$20,000,000
Grant - 2017
California Institute of Regenerative Medicine (CIRM)
Team Size
10+
Employees
Location
Headquarters
$20,000,000 Grant
businesswire

SanBio Receives $20 Million Grant from CIRM for Stroke Clinical Trial